Atrás
Precio CARsgen Therapeutics Holdings Limited (02171.HK)
Gráfico del Precio de Acciones 02171.HK
CARSGEN-B (02171.HK)
CARsgen Therapeutics Holdings Limited
HK$15.07
1.14%
$0.16
Mercado cerrado: Feb 16, 12:00:00 HKT
Estadísticas clave
Cierre Anterior
$14.4
Precio de apertura
$14.9
Rango del día
$14.44 - $15.52
Rango de 52 semanas
$9.44 - $25.6
Volumen
1.0M
Volumen promedio
1.6M
EPS (TTM)
-1.07
Rendimiento de dividendos
--
Cap. de mercado
$8.2B
¿Qué es CARSGEN-B?
CARsgen Therapeutics Holdings Ltd. is a clinical-stage biopharmaceutical company, which engages in discovering, researching, and developing cell therapies. The company is headquartered in Shanghai, Shanghai and currently employs 371 full-time employees. The company went IPO on 2021-06-18. The Company’s main business is engaged in developing chimeric antigen receptor T cell (CAR T) -cell therapies to address clinical needs including but not limited to hematologic malignancies solid tumors and autoimmune diseases. The Company’s main products include zevor-cel (zevorcabtagene autoleucel), satricabtagene autoleucel and allogeneic CAR T-cell products. The firm conducts its business in the domestic and overseas markets.
Características
© 2026 Finture Development Limited. Todos los derechos reservados.